These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3751450

  • 1. Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study.
    Solerte SB, Fioravanti M, Bozzetti A, Schifino N, Patti AL, Fedele P, Viola C, Ferrari E.
    Acta Diabetol Lat; 1986; 23(2):171-7. PubMed ID: 3751450
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
    Guerrero-Romero F, Rodríguez-Morán M, Paniagua-Sierra JR, García-Bulnes G, Salas-Ramírez M, Amato D.
    Clin Nephrol; 1995 Feb; 43(2):116-21. PubMed ID: 7736673
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of pentoxifylline on proteinuria in normotensive patients with diabetes mellitus.
    White JR, Karam JH, Koda-Kimble MA.
    DICP; 1990 Nov; 24(11):1043-5. PubMed ID: 2275224
    [Abstract] [Full Text] [Related]

  • 6. Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
    Solerte SB, Ferrari E.
    Pharmatherapeutica; 1985 Nov; 4(6):341-50. PubMed ID: 4080752
    [Abstract] [Full Text] [Related]

  • 7. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
    Solerte SB, Adamo S, Viola C, Zambianchi E, Ferrari E.
    Ric Clin Lab; 1985 Nov; 15 Suppl 1():515-26. PubMed ID: 4035232
    [Abstract] [Full Text] [Related]

  • 8. Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial.
    Rodriguez-Morán M, González-González G, Bermúdez-Barba MV, Medina de la Garza CE, Tamez-Pérez HE, Martínez-Martínez FJ, Guerrero-Romero F.
    Clin Nephrol; 2006 Jul; 66(1):3-10. PubMed ID: 16878429
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF, Mora C, Muros M, García J.
    J Am Soc Nephrol; 2005 Jul; 16(7):2119-26. PubMed ID: 15917336
    [Abstract] [Full Text] [Related]

  • 11. Retrospective analysis of long-term hemorheologic effects of pentoxifylline in diabetic patients with angiopathic complications.
    Solerte SB, Fioravanti M, Cerutti N, Severgnini S, Locatelli M, Pezza N, Rondanelli M, Trecate L, Balza G, Ferrari E.
    Acta Diabetol; 1997 Aug; 34(2):67-74. PubMed ID: 9325467
    [Abstract] [Full Text] [Related]

  • 12. [Effect of trental on indices kidney function in diabetes mellitus].
    Blagosklonnaia IaV, Mamedov R, Kozlov VV, Emanuél' VL, Kudriashova MI.
    Probl Endokrinol (Mosk); 1982 Aug; 28(3):3-8. PubMed ID: 7100130
    [Abstract] [Full Text] [Related]

  • 13. Pentoxifylline for diabetic kidney disease.
    Shan D, Wu HM, Yuan QY, Li J, Zhou RL, Liu GJ.
    Cochrane Database Syst Rev; 2012 Feb 15; (2):CD006800. PubMed ID: 22336824
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes.
    Rodríguez-Morán M, Guerrero-Romero F.
    Curr Diabetes Rev; 2008 Feb 15; 4(1):55-62. PubMed ID: 18220696
    [Abstract] [Full Text] [Related]

  • 16. Reduction of macroalbuminuria with pentoxifylline in diabetic nephropathy. Report of three cases.
    Gorson DM.
    Diabetes Care; 1998 Dec 15; 21(12):2190-1. PubMed ID: 9839116
    [No Abstract] [Full Text] [Related]

  • 17. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.
    Navarro JF, Mora C, Muros M, Maca M, Garca J.
    Am J Kidney Dis; 2003 Aug 15; 42(2):264-70. PubMed ID: 12900807
    [Abstract] [Full Text] [Related]

  • 18. The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
    McCormick BB, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G.
    Am J Kidney Dis; 2008 Sep 15; 52(3):454-63. PubMed ID: 18433957
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.